For the consolidated results of the 2026 July term, net sales were 13,883 million yen (down 14.1% YoY), operating profit was 494 million yen (down 19.8% YoY), and net income attributable to owners of the parent was 364 million yen (down 22.8% YoY). For 2027 July term, expected results are net sales of 13,500 million yen, operating profit of 100 million yen, and net income of 100 million yen. A briefing session is planned.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4934","jir_company_name":"Premier Anti-Aging Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4934-20260914-01.pdf","jir_short_summary":"For the consolidated results of the 2026 July term, net sales were 13,883 million yen (down 14.1% YoY), operating profit was 494 million yen (down 19.8% YoY), and net income attributable to owners of the parent was 364 million yen (down 22.8% YoY). For 2027 July term, expected results are net sales of 13,500 million yen, operating profit of 100 million yen, and net income of 100 million yen. A briefing session is planned.","jir_summary":"### Overview of Results\nFor the consolidated results for the fiscal year ending July 2026, net sales declined to 13,883 million yen (down 14.1% from the prior year). Operating profit declined to 494 million yen (down 19.8%), while ordinary income was 602 million yen (down 0.5%), remaining broadly flat. Net income attributable to owners of the parent fell to 364 million yen (down 22.8%). By segment, the Anti-Aging business saw a decrease in sales, while the Recovery business maintained growth. Going forward, under the 'Skin for Longevity' strategy, the company will strengthen the dual-brand expansion and group collaboration in the Recovery business.\n\n### Outlook and Cash Flow\nFor the consolidated results of the year ending July 2027, the company projects net sales of 13,500 million yen (down 2.8% YoY), operating profit of 100 million yen (down 80.0%), ordinary income of 100 million yen (down 83.4%), and net income attributable to owners of the parent of 100 million yen (down 72.5%). At year-end, cash and cash equivalents are expected to be 4,951 million yen. Looking ahead, amid rising individual spending and inbound demand, the company aims to restore sales through brand value enhancement and optimization of the channel mix.","jir_financial_highlights":"Net Sales: 13,883 (YoY -14.1%)\nOperating Profit: 494 (YoY -19.8%)\nOrdinary Income: 602 (YoY +0.5%)\nNet Income Attributable to Owners of the Parent: 364 (YoY -22.8%)\nTotal Assets: 10,244\nShareholders' Equity Ratio: 67.6%","jir_category":"","jir_hashtags":"#PremierAntiAging, #FinancialResults, #BrandStrategy, #Duo, #RecoveryBusiness","jir_key_figures":"Net Sales: 13,883 million yen\nOperating Profit: 494 million yen\nNet Income Attributable to Owners of the Parent: 364 million yen","jir_meta_title":"\u3010Premier Anti-Aging\u3011Fiscal 2026 July Term Financial Summary | Net Sales 13,883 million yen (YoY -14.1%)","jir_meta_description":"Analysis of Premier Anti-Aging's consolidated financial summary for the fiscal year ending July 2026. Summary of YoY changes in net sales, operating income, and net income, segment trends, outlook, and cash flow.","jir_og_title":"Premier Anti-Aging | Fiscal 2026 July Term Financial Summary","jir_og_description":"Key points from the fiscal 2026 July term financial summary. Net sales 13,883 million yen, operating profit 494 million yen, net income 364 million yen. Outlook and strategy also highlighted.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59723,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-113808","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n